EN3835 (CCH-aaes)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EN3835 (CCH-aaes), covering 2023-09-08 to 2023-09-08. Get the full timeline:
Most recent: Clinical Trial Update: Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite) [Phase 3]